MeSH Review:

# Bayes Theorem

Rogers,
Brown,
Hahn,
Merritt,
Bretthorst,
Burgess,
Sherry,
Malloy,
Ménard,
Valagussa,
Pilotti,
Gianni,
Biganzoli,
Boracchi,
Tomasic,
Casalini,
Marubini,
Colnaghi,
Cascinelli,
Bonadonna,
Tokui,
Kimata,
Uchida,
Yuasa,
Hayashi,
Itatsu,
Nabeshima,
Sato,
Yoshioka,
Kajihara,
Toyama,
Goda,
Doya,
Kawato,
Huang,
Sivaganesan,
Succop,
Goodman,

**Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. Theory.**Gurney, J.W.*Radiology.*(1993)**Pharmacokinetics of Ibuprofen in children with cystic fibrosis.**Han, E.E., Beringer, P.M., Louie, S.G., Gill, M.A., Shapiro, B.J.*Clinical pharmacokinetics.*(2004)**Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis.**Riantawan, P., Chaowalit, P., Wongsangiem, M., Rojanaraweewong, P.*Chest*(1999)**Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up.**Rogers, D., Brown, R.D., Hahn, M.*Journal of biomolecular screening : the official journal of the Society for Biomolecular Screening.*(2005)**Diagnostic value of SCC, CEA and CYFRA 21.1 in lung cancer: a Bayesian analysis.**Pastor, A., Menéndez, R., Cremades, M.J., Pastor, V., Llopis, R., Aznar, J.*Eur. Respir. J.*(1997)**Bayesian analysis and the GUSTO trial. Global Utilization of Streptokinase and Tissue Plasminogen Activator in Occluded Arteries.**Avins, A.L.*JAMA*(1995)**Value of visual evoked response and oligoclonal bands in cerebrospinal fluid in diagnosis of spinal multiple sclerosis.**Kempster, P.A., Iansek, R., Balla, J.I., Dennis, P.M., Biegler, B.*Lancet*(1987)**Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter's syndrome.**Khan, M.A., Khan, M.K.*Ann. Intern. Med.*(1982)**Molecular analysis reveals tighter social regulation of immigration in patrilocal populations than in matrilocal populations.**Hamilton, G., Stoneking, M., Excoffier, L.*Proc. Natl. Acad. Sci. U.S.A.*(2005)**Are ATM mutations 7271T-->G and IVS10-6T-->G really high-risk breast cancer-susceptibility alleles?**Szabo, C.I., Schutte, M., Broeks, A., Houwing-Duistermaat, J.J., Thorstenson, Y.R., Durocher, F., Oldenburg, R.A., Wasielewski, M., Odefrey, F., Thompson, D., Floore, A.N., Kraan, J., Klijn, J.G., van den Ouweland, A.M., Wagner, T.M., Devilee, P., Simard, J., van 't Veer, L.J., Goldgar, D.E., Meijers-Heijboer, H.*Cancer Res.*(2004)**Predictive value of the P wave at implantation for atrial fibrillation after VVI pacemaker implantation.**Snoeck, J., Decoster, H., Vrints, C., Marchand, X., Kahn, J.C., Verherstraeten, M., Berkhof, M., Franque, L.*Pacing and clinical electrophysiology : PACE.*(1992)**Apolipoprotein E epsilon 4 allele and the lifetime risk of Alzheimer's disease. What physicians know, and what they should know.**Seshadri, S., Drachman, D.A., Lippa, C.F.*Arch. Neurol.*(1995)**Population pharmacokinetics of amikacin in geriatric patients studied with the NPEM-2 algorithm.**Debord, J., Charmes, J.P., Marquet, P., Merle, L., Lachâtre, G.*International journal of clinical pharmacology and therapeutics.*(1997)**Lower diagnostic accuracy of thallium-201 SPECT myocardial perfusion imaging in women: an effect of smaller chamber size.**Hansen, C.L., Crabbe, D., Rubin, S.*J. Am. Coll. Cardiol.*(1996)**The effect of metformin on ovarian stimulation and in vitro fertilization in insulin-resistant women with polycystic ovary syndrome: an open-label randomized cross-over trial.**Fedorcsák, P., Dale, P.O., Storeng, R., Abyholm, T., Tanbo, T.*Gynecol. Endocrinol.*(2003)**Validation of techniques for the prediction of carboplatin exposure: application of Bayesian methods.**Huitema, A.D., Mathôt, R.A., Tibben, M.M., Schellens, J.H., Rodenhuis, S., Beijnen, J.H.*Clin. Pharmacol. Ther.*(2000)**Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.**Odani, A., Hashimoto, Y., Otsuki, Y., Uwai, Y., Hattori, H., Furusho, K., Inui, K.*Clin. Pharmacol. Ther.*(1997)**Automated probabilistic method for assigning backbone resonances of (13C,15N)-labeled proteins.**Lukin, J.A., Gove, A.P., Talukdar, S.N., Ho, C.*J. Biomol. NMR*(1997)**Sources of plasma glucose by automated Bayesian analysis of 2H NMR spectra.**Merritt, M., Bretthorst, G.L., Burgess, S.C., Sherry, A.D., Malloy, C.R.*Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine.*(2003)**Individualization of theophylline dosage: a Bayesian method evaluated in patients with once-daily dosing.**Martz, W., Oellerich, M., Schnabel, D., Sybrecht, G.W.*Therapeutic drug monitoring.*(1991)**A Bayesian analysis of the influence of GSTT1 polymorphism on the cancer risk estimate for dichloromethane.**Jonsson, F., Johanson, G.*Toxicol. Appl. Pharmacol.*(2001)**Microsatellite typing in a paternity case against a deceased man whose two brothers were available for testing.**Tamaki, Y., Fukuda, M., Wang, W., Kishida, T.*Nippon Hoigaku Zasshi*(1996)**Response to cyclophosphamide, methotrexate, and fluorouracil in lymph node-positive breast cancer according to HER2 overexpression and other tumor biologic variables.**Ménard, S., Valagussa, P., Pilotti, S., Gianni, L., Biganzoli, E., Boracchi, P., Tomasic, G., Casalini, P., Marubini, E., Colnaghi, M.I., Cascinelli, N., Bonadonna, G.*J. Clin. Oncol.*(2001)**Hierarchical Bayesian estimation for MEG inverse problem.**Sato, M.A., Yoshioka, T., Kajihara, S., Toyama, K., Goda, N., Doya, K., Kawato, M.*Neuroimage*(2004)**Diagnostic value of computerized exercise testing in men without previous myocardial infarction. A multivariate, compartmental and probabilistic approach.**Detry, J.M., Robert, A., Luwaert, R.J., Rousseau, M.F., Brasseur, L.A., Melin, J.A., Brohet, C.R.*Eur. Heart J.*(1985)**Diagnostic value of the bronchial provocation test with methacholine in asthma. A Bayesian analysis approach.**Perpiñá, M., Pellicer, C., de Diego, A., Compte, L., Macián, V.*Chest*(1993)**Evaluation of a Bayesian method of amikacin dosing in intensive care unit patients with normal or impaired renal function.**Lacarelle, B., Granthil, C., Manelli, J.C., Bruder, N., Francois, G., Cano, J.P.*Therapeutic drug monitoring.*(1987)**Dose adjustment strategy for oral microemulsion formulation of cyclosporine: population pharmacokinetics-based analysis in kidney transplant patients.**Tokui, K., Kimata, T., Uchida, K., Yuasa, H., Hayashi, Y., Itatsu, T., Nabeshima, T.*Therapeutic drug monitoring.*(2004)**Critical analysis of the application of Bayes' theorem to sequential testing in the noninvasive diagnosis of coronary artery disease.**Weintraub, W.S., Madeira, S.W., Bodenheimer, M.M., Seelaus, P.A., Katz, R.I., Feldman, M.S., Agarwal, J.B., Banka, V.S., Helfant, R.H.*Am. J. Cardiol.*(1984)**Statistical assessment of mediational effects for logistic mediational models.**Huang, B., Sivaganesan, S., Succop, P., Goodman, E.*Statistics in medicine.*(2004)